NCT07778316 Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC) Status RECRUITING Phase PHASE3
NCT07745907 A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers Status RECRUITING Phase PHASE1
NCT07737925 LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan Status NOT_YET_RECRUITING Phase PHASE2
NCT07717814 A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity Status COMPLETED Phase PHASE1
NCT07700238 A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP) Status NOT_YET_RECRUITING Phase PHASE3
NCT07684235 Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) Status RECRUITING Phase PHASE3
NCT07684144 Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) Status NOT_YET_RECRUITING Phase PHASE3
NCT07637513 Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07614776 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration Status RECRUITING Phase PHASE3
NCT07598825 A Trial of Inebilizumab in Participants With Autoimmune Hepatitis Status NOT_YET_RECRUITING Phase PHASE3
NCT07590193 A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus Status RECRUITING Phase PHASE1
NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH) Status RECRUITING Phase PHASE3
NCT07545226 Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07531095 Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) Status RECRUITING Phase PHASE1
NCT07526298 Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients Status NOT_YET_RECRUITING Phase N/A
NCT07523711 Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07493512 Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT07478887 Impact of the Corrie Lipids Digital Health Program on Lipid Optimization Status RECRUITING Phase NA
NCT07441252 A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight Status RECRUITING Phase PHASE2